首页> 外文OA文献 >DOP050. The efficacy of vedolizumab by disease activity and prior tumour necrosis factor-alpha antagonist failure in patients with ulcerative colitis or Crohn’s disease: post-hoc analyses from the GEMINI 1 and GEMINI 2 studies

【2h】

DOP050. The efficacy of vedolizumab by disease activity and prior tumour necrosis factor-alpha antagonist failure in patients with ulcerative colitis or Crohn’s disease: post-hoc analyses from the GEMINI 1 and GEMINI 2 studies

机译：DOP050。 Vedolizuab对疾病活动和肿瘤坏死因子-α患者溃疡性结肠炎或CROHN病患者的疗效和先前的肿瘤坏死因子 - 来自Gemini 1和Gemini 2研究的hoc分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者

展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Vedolizumab for ulcerative colitis and Crohn's disease: Results and implications of GEMINI studies [J] . LamM.C.W., BresslerB. Immunotherapy . 2014,第9期

机译：维多珠单抗治疗溃疡性结肠炎和克罗恩氏病：GEMINI研究的结果和意义
2. Efficacy of Vedolizumab in Ulcerative Colitis by Prior Treatment Failure in GEMINI I, a Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial [J] . Feagan Brian, Sands Bruce, Sankoh Serap, Inflammatory bowel diseases . 2012,第12Suppla期

机译：Vedolizumab在GEMINI I中的先前治疗失败对溃疡性结肠炎的疗效，这是一项随机，安慰剂对照，双盲，多中心试验
3. Efficacy of Vedolizumab in Ulcerative Colitis by Prior Treatment Failure in GEMINI I, a Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial [J] . Feagan Brian, Sands Bruce, Sankoh Serap, Inflammatory bowel diseases . 2012,第12Suppla期

机译：Vedolizumab在GEMINI I中的先前治疗失败对溃疡性结肠炎的疗效，这是一项随机，安慰剂对照，双盲，多中心试验
4. Isolation of Mycobacterium avium subspecies paratuberculosis from patients with Crohn's disease, ulcerative colitis and healthy controls: preliminary results [C] . Taddei S, Zambelli A, Montanelli A, International Research Society of Spinal Deformities . 2006

机译：患有克罗恩病，溃疡性结肠炎和健康对照患者的分枝杆菌亚种分枝分枝杆菌分枝杆菌：初步结果
5. Efficacy of Vedolizumab in Fistulising Crohn’s Disease: Exploratory Analyses of Data from GEMINI 2 [O] . Brian G Feagan, David Schwartz, Silvio Danese, -1

机译：维多珠单抗治疗克罗恩病的有效性：来自GEMINI 2的数据探索性分析
6. P573 Comparative effectiveness of second-line biological therapies for Ulcerative colitis and Crohn’s disease in patients with prior failure of anti-tumour necrosis factor treatment [O] . H K Hyun, J Yu, E A Kang, 2021

机译：抗肿瘤坏死因子治疗患者溃疡性结肠炎二线生物疗法对溃疡性结肠炎和克罗恩病的比较有效性

DOP050. The efficacy of vedolizumab by disease activity and prior tumour necrosis factor-alpha antagonist failure in patients with ulcerative colitis or Crohn’s disease: post-hoc analyses from the GEMINI 1 and GEMINI 2 studies

著录项

引文网络

相似文献

相关主题

期刊订阅